We provide you with 20 years of free, institutional-grade data for PRTK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PRTK. Explore the full financial landscape of PRTK stock.
| Reported Date | CIK | Ticker | Type |
|---|
Paratek Pharmaceuticals, Inc(NASDAQ:PRTK) 
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, ...
The information provided in this report about PRTK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.